Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity

Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity

US Patent 11155559 · Granted Oct 26, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrrolotriazine compounds acting as MNK inhibitor2025
Acetophenone oxime compound and application thereof2025
Antibodies for treating malignant tumors and uses thereof2025
Dimethylsulfoximine derivative2025
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibi2025
SGLT2/DPP4 inhibitor and application thereof2025
Indazole-fused cyclic compound2025
Salt form and crystal form of tetrahydrocyclohepta indazole compound2025
Benzopyrimidine compounds and use thereof2025
FGFR inhibitor compound in solid form and preparation method therefor2025
Spiro compound serving as ERK inhibitor, and application thereof2025
Cyclic molecules as Bruton's tyrosine kinase inhibitor2025